Digital Therapeutic vs Psychoeducation for Management of Mild to Moderate Depression in Adolescents

Inclusion Criteria: * Adolescents aged 16-17 years old * Experiencing mild-moderate depression as indicated by a PHQ-8 score between 5-19, inclusive, assessed at screening/baseline * Has regular access to a smartphone (Android or iOS smartphone with a recent supported operating system) with reliable WiFi access or sufficient data to engage with assigned study arm for the duration of the study * Available and committed to engage with the program and complete assessments for an 8-week duration * Able to read and write in English * U.S. resident * Regular, stable dose of antidepressant medications for (e.g. escitalopram/Lexapro, fluoxetine/ Prozac) for at least 60 days at screening with no plans to change medication/dose throughout the study * If currently receiving psychotherapy, then must be in therapy for at least 4 weeks at screening with no changes planned for the duration of the study * Participants must be able to understand and willing to provide informed assent and to comply with all study procedures and restrictions Exclusion Criteria: * Lifetime diagnosis of a psychotic disorder, including schizophrenia and schizoaffective disorder * Lifetime diagnosis of bipolar disorder * Lifetime diagnosis of autistic spectrum disorder or pervasive developmental disorder (e.g. autism, Asperger syndrome, Rett's syndrome, or pervasive developmental disorder not otherwise specified) * Suicidal attempt or ideation with a plan and intent to harm oneself during the last 12 months * History of (a) drug and/or alcohol abuse within the past 12 months (determined by self-report) * Current use of benzodiazepines (e.g. lorazepam, clonazepam, alprazolam, diazepam, triazolam) or certain sleep aids (zolpidem, eszopiclone, zaleplon) * Previous Woebot Application use